Entrepreneur-in-Residence Program

Andrew has been in the startup scene since 1998, based in NYC, Hong Kong, Singapore, Palo Alto and Nashville. He kicked off his career when the Internet was first commercializing as a tech lawyer for Alta Vista, Yahoo, DoubleClick, Salesforce and others pioneers. When Google acquired DoubleClick, Andrew co-founded a financial news business for the Thomson family and when they acquired Reuters (and became Thomson Reuters), Andrew became Publisher of Reuters News.

Andrew returned to America and early-stage tech in 2012 and then co-founded GrowthX, an early-stage VC fund run by go-to-market experts. GrowthX sequenced the path to product-market fit to help their founders reduce the time it takes to get investment-ready for their Series A, and retain more ownership along their journey.
 
Areas of Expertise / Interest:   
Venture Capital, Go-to-Market, Product-Market Fit, Customer Discovery, Market Development

Jim has more than 33 years of device, diagnostic, drug, and biologics experience. He is currently CEO of Relay Life Science. Most recently he served as COO for BioMimetic Therapeutics for 12  years; leading growth from four to 100 employees. He has broad experience in commercial operations, supply chain management, product development, tech transfer, quality, regulatory, IT, and facilities management for drug, device, biologics, combination products, and bulk drug products. His experience spans early stage research through all phases of development, product launch, and routine commercial operations. Jim is also head of the LifeScienceTN Mentor program and a member of NueCura, an angel investment network in Brentwood, TN.

Mr. Rousos is currently a founder of The Innovation Studio, a venture studio is an enterprise that founds, operates, manages, and sells startup companies. The Studio partners with large companies to identify pressing industry-wide problems that can be solved using industrial artificial intelligence. Prior to that, he was the Director, Economic and New Venture Development, in the Vanderbilt Center for Technology Transfer and Commercialization. That group launches and supports new companies in which Vanderbilt holds equity resulting from a license or a direct investment. Mr. Rousos is also an investor, an entrepreneur, and has served on a number of for-profit, non-profit, and trade association boards of directors. Prior to that, Mr. Rousos served in senior-level business and legal positions with large companies and startups and practiced law. He received his Juris Doctor degree from the University of Pittsburgh.